STAT3 and hepatocellular carcinoma: Studies conducted by Li et al. revealed that the silencing of STAT3 in the hepatocellular carcinoma model reduced glycolysis-related gene—Hexokinase 2 (HK2)—expression observed at the mRNA and protein levels.